Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-021267

JUNIPER PHARMACEUTICALS INC · JNP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Mar 19, 2018
Accepted (ET)
Mar 22, 2018 · 4:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMar 19, 2018A5,625$0.00A13,657D
Common StockF2holding———250ISee Footnote
Common StockF3holding———250ISee Footnote
Common StockF4holding———250ISee Footnote
Common StockF5holding———8,000ISee Footnote
Common StockF6holding———9,700ISee Footnote
Common StockF7holding———41,000ISee Footnote
Common StockF8holding———14,500ISee Footnote
Common StockF9holding———2,001ISee Footnote
Common StockF10holding———28,000ISee Footnote
Common StockF11holding———6,250ISee Footnote
Common StockF12holding———875ISee Footnote
Common StockF13holding———100,000ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses